Currently, there are very few treatment options for those
with Alzheimer’s disease (AD). Clinical trials are the only way for new
treatments to be developed that can prevent progression of the disease.
Clinical trials also help us learn more about AD. At the Byrd Institute, we are
involved in several research studies, adding new studies regularly. We offer a
range of participation options including prevention studies for older people
without memory loss and studies that include treatment of mild cognitive
impairment (MCI) and mild to moderate AD. Some of our trials are
observation-only, while others involve pills, injections, or infusions.
Additionally, many trials include special blood tests, cognitive testing, and
brain imaging (PET scans) to detect the protein accumulation associated with
memory loss. Below is a list of opportunities to participate in our studies.
The Byrd Institute is very pleased to announce a new study
we are currently conducting that is aimed to delay or prevent Alzheimer's.
Currently Enrolling Clinical Trials
> For Individuals WITH Memory Loss
- A 4-year observational study involving cognitive testing and neuroimaging, which may help to
learn more about Alzheimer’s disease. This study is for individuals 55-90 years old with mild
cognitive impairment or mild Alzheimer’s disease.
- A 4.5-year trial
investigating an infusion-based treatment which may reduce the spreading of tau
tangles in the brain and slow cognitive decline. This study is for individuals 55-80
years old with early Alzheimer’s disease.
> For Individuals WITHOUT Memory Loss
- A 5-year study involving cognitive testing and neuroimaging, which is intended to help recruit for future Alzheimer's prevention studies. This study is for individuals 50-85 years old who currently have no memory problems.
- A
4-year “prevention” study investigating an infusion-based treatment which may
reduce amyloid plaque in the brain. This study is for individuals 55-80 years
old who currently have no memory problems.
Upcoming Clinical Trials
> For Individuals WITH Memory loss
- A 20.5-month trial investigating an oral
treatment which may slow the progression of symptoms of early Alzheimer’s
disease. This study is for patients 50-89 years old with mild cognitive
impairment due to Alzheimer’s disease or mild Alzheimer’s disease.
> For Individuals WITHOUT Memory Loss
- A
2-week study involving a one-time blood draw to determine the accuracy and
reliability of the plasma P-tau217 assay (study test). This study is for
individuals 50 years of age and older who currently have no memory problems.
We always have new trials just around the corner. Please check back with us for updates!
For more information about our clinical research, contact
Anna Sladky at (813) 974-4904 or asladky@usf.edu
Links for Finding Clinical Trials
